Different pathways to Alzheimer’s disease

Slides:

Advertisements

Similar presentations

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.

Advertisements

Sleep disruption changes across the disease trajectory: Pilot findings from the healthy patterns sleep study Nancy A. Hodgson, Albert J. Safi Alzheimer's.

Capillary dysfunction in Alzheimer's disease

DIAGNOSTIC ACCURACY AND CONFIDENCE IN THE CLINICAL DETECTION OF COGNITIVE IMPAIRMENT IN EARLY-STAGE PARKINSON’S DISEASE Kathryn A. Wyman-Chick, Phillip.

Volume 3, Issue 4, Pages (November 2017)

Relationship between Microstructural Degeneration of the Corpus Callosum, White Matter Hyperintensities, and Motor Function in Cognitively Intact Elderly

Manuela Tondelli, Gordon K. Wilcock, Paolo Nichelli, Celeste A

Hilkka Liedes, Jyrki Lötjönen, Gerald P. Novak, Mark Forrest Gordon

Comparison of accelerated and nonaccelerated MRI in ADNI: Effects on measures of brain and ventricular volumes and rates of atrophy Kelvin Leung, Casper.

MTL SUBREGIONAL MORPHOMETRY USING HIGH RESOLUTION MRI IN ADNI2

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

A SYSTEMATIC REVIEW AND META-ANALYSIS COMPARING QUALITY-OF-LIFE RATINGS FROM FAMILY AND PAID CAREGIVERS OF PEOPLE WITH DEMENTIA RESIDING IN CARE HOMES

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Interaction network of tau protein, beta-amyloid protein, and amyloid protein precursor under oxidative stress in Alzheimer’s disease Eduardo de Souza/S.

INCREASED CSF LEVELS OF BIOMARKERS FOR NEURODEGENERATION IN FTLD-GRN MUTATION CARRIERS Joery Goossens, Sara Van Mossevelde, Tobi Van den Bossche, Anne.

Longitudinal evaluation of criteria for subjective cognitive decline and preclinical Alzheimer's disease in a memory clinic sample Marie Eckerström,

The differential diagnosis of amnestic mild cognitive impairment and Alzheimer's disease dementia by hippocampal volume measurement with MR in a chinese.

Localization of Hippocampal atrophy in Alzheimer's disease

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

INVESTIGATION OF 99MTC-LABELED CLIOQUINOL DERIVATIVE ON AMYLOID PLAQUE SPECIFICITY BY USING AN ANIMAL MODEL OF ALZHEIMER'S DISEASE Ayfer Yurt KIlçar,

A NOVEL NEUROIMAGING APPROACH TO CAPTURE COGNITIVE RESERVE

Christine Bredfeldt, Kristen Rice, Lisa Alecxih

KETOGENIC DIET EFFECTS ON BRAIN KETONE METABOLISM AND ALZHEIMER'S DISEASE CSF BIOMARKERS Suzanne Craft, Bryan J. Neth, Akiva Mintz, Kiran Sai, Nora Shively,

The effect of using a conditional discrimination procedure to teach name-face relation to a person diagnosed with dementia Hanna S. Steingrimsdottir,

Alzheimer's disease biomarker-based clusters predict amyloid accumulation and cognitive decline in a preclinical cohort: Findings from the wisconsin registry.

Application of Resource Utilization in Dementia (RUD) instrument in a global setting Anders Wimo, Anders Gustavsson, Linus Jönsson, Bengt Winblad, Ming-Ann.

LATENT-FACTOR STRUCTURE OF THE DELCODE STUDY NEUROPSYCHOLOGICAL TEST BATTERY Steffen Wolfsgruber, Luca Kleineidam, Jannis Guski, Oliver Peters, Katharina.

APOE GENOTYPE MODIFIES THE EFFECTS OF AEROBIC TRAINING ON BRAIN GLUCOSE METABOLISM IN SUBJECTS WITH MILD COGNITIVE IMPAIRMENT Fabio H.G. Porto, Artur.

HYPERGLYCEMIA: PREDISPOSITION FOR MICROEMBOLI, STROKE, AND WHITE MATTER CHANGES Leila Parand, Saif Bushnaq, Yue Wang, Lenora Mathes, Dinesh Jillella,

DETECTING COGNITIVE DISORDERS USING THE MUISTIKKO WEB-BASED COGNITIVE TEST BATTERY: VALIDATION IN THREE COHORTS Teemu Paajanen, Shadi Mahdiani, Marie.

Marjolein Bulk, Linda van der Graaf, Walid M

Colin Groot, Chris W. J. van der Weijden, Wiesje M

Japanese brain bank network for neuroscience research

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

BIOLOGICAL PATHWAYS FOUND IN COMMON BETWEEN ALZHEIMER’S DISEASE AND MAJOR DEPRESSION: A STUDY ON MICRORNA EXPRESSION IN A SYSTEMATIC REVIEW Ana Paula.

Early Dementia Distinguishing AD From MCI

Volume 81, Issue 6, Pages (March 2014)

Community environment and incident dementia: Results from the three-city study Claudine Berr, Laure Anne Gutierrez, Sylvaine Artero, Catherine Helmer,

Effect of hypertension and antihypertensive medication on executive function, brain atrophy, and white matter hyperintensities Shannon L. Risacher, Li.

Biomarker Modeling of Alzheimer’s Disease

Application of Resource Utilization in Dementia (RUD) instrument in a global setting Anders Wimo, Anders Gustavsson, Linus Jönsson, Bengt Winblad, Ming-Ann.

Volume 81, Issue 6, Pages (March 2014)

LIFESPAN OF ONE FOCUSED ULTRASOUND MEDIATED BLOOD-BRAIN BARRIER TREATMENT IN A MOUSE MODEL OF ALZHEIMER'S DISEASE Charissa Poon, Kullervo Hynynen Alzheimer's.

Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective Matthew Baumgart, Heather M. Snyder,

LINKING GENE PATHWAYS AND BRAIN ATROPHY IN ALZHEIMER'S DISEASE

Shruti Mishra, Brian Andrew Gordon, Karl A

Comparison of visual and quantitative florbetapir-PET reads in subjects with early Alzheimer's disease for assessing amyloid burden Bradley Wyman, Yahong.

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

The incremental diagnostic value of 18F-florbetapir imaging in naturalistic patients with cognitive impairment: The India-FBP study Marina Boccardi,

Added value of 11C-PiB-PET imaging in the diagnosis of Alzheimer's disease Kristian Frederiksen, Anne-Mette Hejl, Ian Law, Steen Hasselbalch, Gunhild.

Mark D. Meadowcroft, Douglas G. Peters, Carson J

COGNITIVE COMPLAINTS IN OLDER ADULTS AT RISK FOR ALZHEIMER’S DISEASE ARE ASSOCIATED WITH ALTERED RESTING STATE NETWORKS Joey A. Contreras, Joaquín Goñi,

MR-less cortical surface-projection of PET images from 11C- and 18F-labeled radiotracers Vincent Doré, Pierrick Bourgeat, Luping Zhou, Jurgen Fripp,

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

GREY MATTER CONNECTIVITY IS ASSOCIATED WITH CLINICAL PROGRESSION IN NON-DEMENTED, AMYLOID POSITIVE PATIENTS Betty M. Tijms, Mara ten Kate, Sander C.J.

DIFFERENCES IN ANALYTICAL SELECTIVITY OF β-AMYLOID (1-42) IMMUNOASSAYS EXPLAIN DISCORDANT RESULTS IN STUDY COMPARISONS Hugo Marcel Vanderstichele, Emeric.

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Intersite variability of CSF Alzheimer’s disease biomarkers in clinical setting Julien Dumurgier, Olivier Vercruysse, Claire Paquet, Stéphanie Bombois,

Alzheimer's Association towards Guidelines for Dementia Care Practice: Recommendations with emphasis on high-quality, person-centered care in long-term.

Brain amyloid deposition and metabolism in early and late mild cognitive impairment Jared Rowley, Liyong Wu, Sara Mohades, Marina Dauar, Antoine Leuzy,

Tharick A. Pascoal, Sulantha S

Different pathways to Alzheimer’s disease

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

INTRINSIC CONNECTIVITY NETWORKS IN POSTERIOR CORTICAL ATROPHY: A ROLE FOR THE PULVINAR? Carolyn A. Fredericks, Jesse Brown, Jersey Deng, Rik Ossenkoppele,

Automated detection of beta-amyloid–related cortical and subcortical signal changes in a transgenic model of Alzheimer's disease using high-field MRI

Extracting white matter hyperintensities in Alzheimer's disease risk and aging studies using supervised segmentation methods Vamsi Ithapu, Vikas Singh,

BRAIN AMYLOIDOSIS AND COGNITIVE DECLINE IN MCI: 12-MONTH FOLLOW-UP

Michael Navitsky, Abhinay D. Joshi, Michael D. Devous, Michael J

Figure 1 NMF in ADD patients and classification of prodromal Alzheimer’s disease participants. Grey matter ... Figure 1 NMF in ADD patients and classification.

Presentation transcript:

Different pathways to Alzheimer’s disease Different pathways to Alzheimer’s disease? atrophy, hypometabolism, and beta-amyloid deposition in diagnostic groups at increased risk Miranka Wirth, Alexandre Bejanin, Eider M. Arenaza-Urquijo, Julie Gonneaud, Renaud La Joie, Brigitte Landeau, Audrey Perrotin, Florence Mézenge, Vincent de La Sayette, Béatrice Desgranges, Gaël Chételat Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 7, Pages P2-P3 (July 2015) DOI: 10.1016/j.jalz.2015.06.004 Copyright © 2015 Terms and Conditions

Figure 1 Voxel-wise intra-modality comparisons between regional degrees of atrophy, hypermetabolism and amyloid deposition in diagnostic groups with 1A. Mild Cognitive Impairment (MCI), 1B. Subjective Memory Decline (SCD), 1C. CN APOE4 carriers as well as 0. AD patients (for visual comparison). Contrast maps were displayed on the left hemisphere thresholded at t -values of p < 0.001 uncorrected, k = 20. Alzheimer's & Dementia: The Journal of the Alzheimer's Association 2015 11, P2-P3DOI: (10.1016/j.jalz.2015.06.004) Copyright © 2015 Terms and Conditions